Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Pulmonary Hypertension, July 2022

Free Subscription


Abstracts

Retrieve all available abstracts of the following 152 articles:
HTML format


 

Single Articles

  1. TAHA F, Southgate L
    Molecular genetics of pulmonary hypertension in children.
    Curr Opin Genet Dev. 2022;75:101936.
    PubMed    
    Abstract available

  2. RUEDA DA, Aguirre RA, Fonzo HD, Mazzei ME, et al
    Severe arterial pulmonary hypertension in a 34-year-old patient.
    Arch Cardiol Mex. 2022;92:418-419.
    PubMed    



  3. Erratum: Clinical Differences and Outcomes between Methamphetamine-associated and Idiopathic Pulmonary Arterial Hypertension in the Pulmonary Hypertension Association Registry.
    Ann Am Thorac Soc. 2022;19:1243-1244.
    PubMed    



  4. Erratum: Obesity in Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association Registry.
    Ann Am Thorac Soc. 2022;19:1242.
    PubMed    


  5. WOLTERS AEP, Wolters AJP, van Kraaij TDA, Kietselaer BLJH, et al
    Echocardiographic estimation of pulmonary hypertension in COVID-19 patients.
    Neth Heart J. 2022 Jun 30. pii: 10.1007/s12471-022-01702.
    PubMed    
    Abstract available

  6. CARAVITA S, Picariello C, Garascia A, Misuraca L, et al
    [Pulmonary hypertension: pre- or post-capillary? The role of provocative tests in the cath lab].
    G Ital Cardiol (Rome). 2022;23:533-541.
    PubMed    
    Abstract available

  7. MALIGIREDDY AR, Shore S, Sreenivas Kumar A, Harikrishnan S, et al
    Current status and barriers in pulmonary hypertension care delivery in India: A qualitative analysis.
    Pulm Circ. 2022;12:e12094.
    PubMed    
    Abstract available

  8. WANG N, Guo Z, Gong X, Kang S, et al
    A Nomogram for Predicting the Risk of Pulmonary Hypertension for Patients with Chronic Obstructive Pulmonary Disease.
    Int J Gen Med. 2022;15:5751-5762.
    PubMed    
    Abstract available

  9. CHANG S, Wu J, Jin J, Shi H, et al
    Aldehyde Dehydrogenase 2 (ALDH2) Elicits Protection against Pulmonary Hypertension via Inhibition of ERK1/2-Mediated Autophagy.
    Oxid Med Cell Longev. 2022;2022:2555476.
    PubMed    
    Abstract available

  10. WANG CH, Chen JJ, Ge JJ, Ma XL, et al
    [Risk factors and short-term prognosis of early pulmonary hypertension in preterm infants].
    Zhonghua Er Ke Za Zhi. 2022;60:682-687.
    PubMed    
    Abstract available

  11. CULLIVAN S, Lennon D, Meghani S, Minnock C, et al
    Incidence and outcomes of pulmonary hypertension in the Ireland.
    BMJ Open Respir Res. 2022;9.
    PubMed    
    Abstract available

  12. FERNANDES CJCDS, Ota-Arakaki JS, Campos FTAF, Correa RA, et al
    Brazilian Thoracic Society recommendations for the diagnosis and treatment of chronic thromboembolic pulmonary hypertension.
    J Bras Pneumol. 2022;46:e20200204.
    PubMed    
    Abstract available

  13. PARK J, Banerjee S, Hong J, Umar S, et al
    Response by Park et al to Letter Regarding Article, "Transcriptomic Analysis of Right Ventricular Remodeling in Two Rat Models of Pulmonary Hypertension: Identification and Validation of Epithelial-to-Mesenchymal Transition in Human Right Ventricular
    Circ Heart Fail. 2022 Jun 29:101161CIRCHEARTFAILURE122008632.
    PubMed    


  14. NAING P, Kangaharan N, Scalia GM, Strange G, et al
    Pulmonary Hypertension in Remote and Disadvantaged Population: Overcoming Unique Challenges for Improved Outcomes.
    Intern Med J. 2022 Jun 28. doi: 10.1111/imj.15860.
    PubMed    
    Abstract available

  15. SURAYA R, Nagano T, Ryanto GRT, Effendi WI, et al
    Budesonide/glycopyrronium/formoterol fumarate triple therapy prevents pulmonary hypertension in a COPD mouse model via NFkappaB inactivation.
    Respir Res. 2022;23:173.
    PubMed    
    Abstract available

  16. SHARMA M, Bellio MA, Benny M, Kulandavelu S, et al
    Mesenchymal Stem Cell-derived Extracellular Vesicles Prevent Experimental Bronchopulmonary Dysplasia Complicated By Pulmonary Hypertension.
    Stem Cells Transl Med. 2022 Jun 27. pii: 6618502. doi: 10.1093.
    PubMed    
    Abstract available

  17. DUAN A, Li X, Jin Q, Zhang Y, et al
    Prognostic implication of noninvasive right ventricle-to-pulmonary artery coupling in chronic thromboembolic pulmonary hypertension.
    Ther Adv Chronic Dis. 2022;13:20406223221102803.
    PubMed    
    Abstract available

  18. TABELING C, Gonzalez Calera CR, Lienau J, Hoppner J, et al
    Endothelin B Receptor Immunodynamics in Pulmonary Arterial Hypertension.
    Front Immunol. 2022;13:895501.
    PubMed    
    Abstract available

  19. BAO C, He Q, Wang H, Sun Y, et al
    Artemisinin and Its Derivate Alleviate Pulmonary Hypertension and Vasoconstriction in Rodent Models.
    Oxid Med Cell Longev. 2022;2022:2782429.
    PubMed    
    Abstract available

  20. RUBACKOVA POPELOVA J, Tomek J, Tomkova M, Zivna R, et al
    Normalization of Four Different Types of Pulmonary Hypertension After Atrial Septal Defect Closure.
    Front Cardiovasc Med. 2022;9:876755.
    PubMed    
    Abstract available

  21. BUFFONI I, Buratti S, Mallamaci MF, Pezzato S, et al
    Sudden Onset of Severe Pulmonary Hypertension in a Preterm Infant: A Case Report on the Role of Maternal Use of Serotonin Re-Uptake Inhibitors During Pregnancy and Concurrent Risk Factors.
    Front Pediatr. 2022;10:855419.
    PubMed    
    Abstract available

  22. REHMAN A, Darira J, Ahmed MS, Hamid K, et al
    Evaluating Signs of Pulmonary Hypertension on Computed Tomography and Correlating With Echocardiography: A Study at a Tertiary Care Hospital.
    Cureus. 2022;14:e25319.
    PubMed    
    Abstract available

  23. INOUE N, Morikawa S
    Unusual case of cerebral embolism after initiation of selexipag for sarcoidosis-related pulmonary hypertension: a case report.
    Radiol Case Rep. 2022;17:3009-3014.
    PubMed    
    Abstract available

  24. SCHIMMELPENNINK MC, Meek DB, Vorselaars ADM, Langezaal LCM, et al
    Characterization of the PF-ILD phenotype in patients with advanced pulmonary sarcoidosis.
    Respir Res. 2022;23:169.
    PubMed    
    Abstract available

  25. SUN X, Shi X, Cao Y, Zhu H, et al
    Variation of PetCO2 during incremental exercise and severity of IPAH and CTEPH.
    BMC Pulm Med. 2022;22:249.
    PubMed    
    Abstract available

  26. XU D, Hu YH, Gou X, Li FY, et al
    Oxidative Stress and Antioxidative Therapy in Pulmonary Arterial Hypertension.
    Molecules. 2022;27.
    PubMed    
    Abstract available

  27. VAN UDEN D, Koudstaal T, van Hulst JAC, Vink M, et al
    Peripheral Blood T Cells of Patients with IPAH Have a Reduced Cytokine-Producing Capacity.
    Int J Mol Sci. 2022;23.
    PubMed    
    Abstract available

  28. JIANG Y, Hei B, Hao W, Lin S, et al
    Clinical value of lncRNA SOX2-OT in pulmonary arterial hypertension and its role in pulmonary artery smooth muscle cell proliferation, migration, apoptosis, and inflammatory.
    Heart Lung. 2022;55:16-23.
    PubMed    
    Abstract available

  29. YANG EL, Levy PT, Critser PJ, Dukhovny D, et al
    The clinical and cost utility of cardiac catheterizations in infants with bronchopulmonary dysplasia.
    J Pediatr. 2022 Apr 14. pii: S0022-3476(22)00323.
    PubMed    
    Abstract available

  30. NI S, Ji T, Dong J, Chen F, et al
    Immune Cells in Pulmonary Arterial Hypertension.
    Heart Lung Circ. 2022;31:934-943.
    PubMed    
    Abstract available

  31. SAIKI C, Kashiwado Y, Yokoyama T, Ayano M, et al
    Successful transition from intravenous epoprostenol to oral selexipag and inhaled iloprost in a case of severe pulmonary arterial hypertension associated with systemic lupus erythematosus.
    Mod Rheumatol Case Rep. 2022;6:183-188.
    PubMed    
    Abstract available

  32. MICHAUD E, Pan M, Aggarwal V
    Catheter-based therapies in acute and chronic pulmonary embolism.
    Curr Opin Cardiol. 2021;36:704-710.
    PubMed    
    Abstract available

  33. BASURTO D, Maria Russo F, Papastefanou I, Bredaki E, et al
    Pulmonary hypertension in congenital diaphragmatic hernia: ANTENATAL PREDICTION AND IMPACT ON NEONATAL MORTALITY.
    Prenat Diagn. 2022 Jul 7. doi: 10.1002/pd.6207.
    PubMed    
    Abstract available

  34. ABOZEED M, Conic S, Bullen J, Rizk A, et al
    Dual energy CT based scoring in chronic thromboembolic pulmonary hypertension and correlation with clinical and hemodynamic parameters: a retrospective cross-sectional study.
    Cardiovasc Diagn Ther. 2022;12:305-313.
    PubMed    
    Abstract available

  35. RUOSS JL, Moronta SC, Bazacliu C, Giesinger RE, et al
    Management of cardiac dysfunction in neonates with pulmonary hypertension and the role of the ductus arteriosus.
    Semin Fetal Neonatal Med. 2022 Jun 11:101368. doi: 10.1016/j.siny.2022.101368.
    PubMed    
    Abstract available

  36. STONE A, Poulik J, Koussa S, Xin Y, et al
    Early histological changes of bronchopulmonary dysplasia and pulmonary hypertension may precede clinical diagnosis in preterm infants.
    Early Hum Dev. 2022;171:105612.
    PubMed    
    Abstract available

  37. OMOTE K, Sorimachi H, Obokata M, Reddy YNV, et al
    Pulmonary vascular disease in pulmonary hypertension due to left heart disease: pathophysiologic implications.
    Eur Heart J. 2022 Jul 7. pii: 6633254. doi: 10.1093.
    PubMed    
    Abstract available

  38. HOEPER MM, Rosenkranz S
    Was Paul Wood wrong about pre-capillary pulmonary hypertension protecting against pulmonary congestion in left heart disease?
    Eur Heart J. 2022 Jul 7. pii: 6633248. doi: 10.1093.
    PubMed    


  39. ZHANG Z, Liu C, Bai Y, Li X, et al
    Pipersentan: A De Novo Synthetic Endothelin Receptor Antagonist that Inhibits Monocrotaline- and Hypoxia-Induced Pulmonary Hypertension.
    Front Pharmacol. 2022;13:920222.
    PubMed    
    Abstract available

  40. KOSANOVICH CM, Pi H, Handen A, Schikowski E, et al
    Improved hospitalization rates in a specialty center for heart failure with preserved ejection fraction and pulmonary hypertension.
    Pulm Circ. 2022;12.
    PubMed    
    Abstract available

  41. JACOBS JA, Jahangir E, Ryan JJ
    Differentiating pulmonary hypertension associated with protein kinase inhibitors.
    Pulm Circ. 2022;12:e12075.
    PubMed    
    Abstract available

  42. KALLONEN J, Korsholm K, Bredin F, Corbascio M, et al
    Association of residual pulmonary hypertension with survival after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension.
    Pulm Circ. 2022;12:e12093.
    PubMed    
    Abstract available

  43. FORFIA P, Ferraro B, Vaidya A
    Recognizing pulmonary hypertension following pulmonary thromboendarterectomy: A practical guide for clinicians.
    Pulm Circ. 2022;12:e12073.
    PubMed    
    Abstract available

  44. FUKAMACHI D, Okumura Y
    Pulmonary Circulation with Chronic Thromboembolic Pulmonary Hypertension.
    Intern Med. 2022 Jul 5. doi: 10.2169/internalmedicine.0017.
    PubMed    


  45. YAGMUR B, Nalbantgil S, Kayikcioglu M
    Two Case Reports of Progressive Pulmonary Hypertension with Type-1 Gaucher Disease: Efficient PAH-Specific Therapy and 1-Year Follow-Up.
    Anatol J Cardiol. 2022;26:584-588.
    PubMed    


  46. SHI Y, Dong X, Hu X, Weng L, et al
    Cross-cultural validation of the Chinese version of the EmPHasis-10 questionnaire in connective tissue disease patients with pulmonary arterial hypertension and its relationship with risk stratification.
    BMC Pulm Med. 2022;22:264.
    PubMed    
    Abstract available

  47. KJELLSTROM B, Bouzina H, Bjorklund E, Beaudet A, et al
    Five year risk assessment and treatment patterns in patients with chronic thromboembolic pulmonary hypertension.
    ESC Heart Fail. 2022 Jul 4. doi: 10.1002/ehf2.14033.
    PubMed    
    Abstract available

  48. JONES CB, Crossland DS
    The interplay between pressure, flow, and resistance in neonatal pulmonary hypertension.
    Semin Fetal Neonatal Med. 2022 Jun 18:101371. doi: 10.1016/j.siny.2022.101371.
    PubMed    
    Abstract available

  49. GIACOMAZZI F, Mazzaccaro D, Schiaffino S, Giannetta M, et al
    Radiologic evolution of pulmonary arterial thrombosis associated with SARS-CoV-2 pneumonia.
    Vasa. 2022;51:263-264.
    PubMed    


  50. DONG J, Jiang XM, Zhang J, Xie DJ, et al
    Pulmonary artery denervation significantly improves right ventricular longitudinal strain in pulmonary hypertension induced by dehydromonocrotaline.
    Minerva Med. 2022 Jul 5. pii: S0026-4806.22.08259.
    PubMed    


  51. WU J, Huang Q, Li Q, Gu Y, et al
    Increased Methyl-CpG-Binding Domain Protein 2 Promotes Cigarette Smoke-Induced Pulmonary Hypertension.
    Front Oncol. 2022;12:879793.
    PubMed    
    Abstract available

  52. MURALI S, Khanal S, Banerjee S, Christie O, et al
    Pause at Your Own Peril: A Case Series on Rebound Pulmonary Hypertension.
    Cureus. 2022;14:e25552.
    PubMed    
    Abstract available

  53. XU W, Sun X, Tao X, Wang D, et al
    Characteristics of Right Ventricular Blood Flow in Patients With Chronic Thromboembolic Pulmonary Hypertension: An Analysis With 4-Dimensional Flow Cardiovascular Magnetic Resonance Imaging.
    Front Cardiovasc Med. 2022;9:900301.
    PubMed    
    Abstract available

  54. KUSUNOSE K, Hirata Y, Yamaguchi N, Kosaka Y, et al
    Deep Learning for Detection of Exercise-Induced Pulmonary Hypertension Using Chest X-Ray Images.
    Front Cardiovasc Med. 2022;9:891703.
    PubMed    
    Abstract available

  55. RODERBURG C, Loosen SH, Hippe HJ, Luedde T, et al
    Pulmonary hypertension is associated with an increased incidence of cancer diagnoses.
    Pulm Circ. 2022;12:e12000.
    PubMed    
    Abstract available

  56. MINHAS J, Narasimmal SP, Bull TM, De Marco T, et al
    Corrigendum for health-related quality of life and hospitalizations in chronic thromboembolic pulmonary hypertension versus idiopathic pulmonary arterial hypertension: And analysis from the Pulmonary Hypertension Association Registry.
    Pulm Circ. 2022;12:e12085.
    PubMed    
    Abstract available

  57. WATANABE H
    [Role of NO-cGMP-PKG axis in pulmonary arterial hypertension].
    Nihon Yakurigaku Zasshi. 2022;157:221-225.
    PubMed    
    Abstract available

  58. VEIGA OLIVEIRA P, Madeira M, Ranchordas S, Nolasco T, et al
    Triple valve surgery: long-term follow-up from a single centre.
    Port J Card Thorac Vasc Surg. 2022;29:23-29.
    PubMed    
    Abstract available

  59. JENTZER JC
    Under pressure: pulmonary hypertension and right ventricular dysfunction in cardiac arrest.
    Resuscitation. 2022 Jun 29. pii: S0300-9572(22)00584.
    PubMed    


  60. DE BIE FR, Halline CG, Kotzur T, Hayes K, et al
    Prenatal treprostinil reduces the pulmonary hypertension phenotype in the rat model of congenital diaphragmatic hernia.
    EBioMedicine. 2022;81:104106.
    PubMed    
    Abstract available

  61. LI C, Zhu H, Zhang S, Meng F, et al
    Corrigendum to "Astragaloside IV ameliorates pulmonary vascular remodeling in hypoxia-induced pulmonary hypertension by restraining the T follicular helper cell response and expanding T follicular regulatory cell response".
    Phytomedicine. 2022;104:154267.
    PubMed    


  62. ATA F, Khan AA, Yousaf Z, Choudry H, et al
    The clinical characteristics and outcomes of patients with pulmonary hypertension in association with hyperthyroid state: A systematic review.
    Medicine (Baltimore). 2022;101:e29832.
    PubMed    
    Abstract available

  63. YAMAGUCHI K, Ogihara Y, Fujimoto N, Nomura Y, et al
    Histopathological Findings of Pulmonary Hypertension With Elevated Pulmonary Arterial Wedge Pressure in Hereditary Hemorrhagic Telangiectasia.
    Circ Rep. 2022;4:287-288.
    PubMed    


  64. AL-NAAMANI N
    Let's Talk about Sex: Sexual Health in Pulmonary Arterial Hypertension.
    Ann Am Thorac Soc. 2022;19:1097-1099.
    PubMed    


  65. FRIEDMAN SH, Veglia M, Gregg D, Argula RG, et al
    Progressive Dyspnea in a Woman with Congenital Heart Disease and Pulmonary Arterial Hypertension.
    Ann Am Thorac Soc. 2022;19:1221-1225.
    PubMed    


  66. HEINONEN E, Forsberg L, Norby U, Wide K, et al
    Neonatal morbidity after fetal exposure to antipsychotics: a national register-based study.
    BMJ Open. 2022;12:e061328.
    PubMed    
    Abstract available

  67. GUO T, He C, Venado A, Zhou Y, et al
    Extracellular Matrix Stiffness in Lung Health and Disease.
    Compr Physiol. 2022;12:3523-3558.
    PubMed    
    Abstract available

  68. LIN QF, Rao JH, Luo SM, Wang QM, et al
    Relation between endothelial nitric oxide synthase genetic polymorphisms and pulmonary arterial hypertension in newborns with congenital heart disease.
    Clin Exp Hypertens. 2022 Jun 14:1-6. doi: 10.1080/10641963.2022.2085736.
    PubMed    
    Abstract available

  69. CIURZYNSKI M, Kurzyna M, Kopec G, Blaszczak P, et al
    An expert opinion of the Polish Cardiac Society Working Group on Pulmonary Circulation on screening for chronic thromboembolic pulmonary hypertension patients after acute pulmonary embolism: Update.
    Kardiol Pol. 2022;80:723-732.
    PubMed    
    Abstract available

  70. BADEA R, Dorobantu DM, Sharabiani MTA, Predescu LM, et al
    Left main coronary artery compression by dilated pulmonary artery in pulmonary arterial hypertension: a systematic review and meta-analysis.
    Clin Res Cardiol. 2022;111:816-826.
    PubMed    
    Abstract available

  71. YEE DC, Banerjee D, Vargas SE, Allahua M, et al
    Sexual Health-related Quality of Life in Women with Pulmonary Arterial Hypertension: Compensating for Loss.
    Ann Am Thorac Soc. 2022;19:1122-1129.
    PubMed    
    Abstract available

  72. HE YY, Yan Y, Chen JW, Liu S, et al
    Plasma metabolomics in the perioperative period of defect repair in patients with pulmonary arterial hypertension associated with congenital heart disease.
    Acta Pharmacol Sin. 2022;43:1710-1720.
    PubMed    
    Abstract available

  73. YUGUCHI T, Sano H, Nakajima K, Ikura Y, et al
    Pulmonary Tumor Thrombotic Microangiopathy Caused by Recurrent Gastric Cancer 26 Years After Total Gastrectomy.
    Intern Med. 2022;61:1969-1972.
    PubMed    
    Abstract available

  74. RAMIREZ-RAMOS CF, Saldarriaga-Giraldo C, Yepes-Calderon M, Castilla-Agudelo G, et al
    Clinical and hemodynamic outcomes and mortality risk factors in patients undergoing pulmonary thromboendarterectomy.
    Arch Cardiol Mex. 2022;92:312-319.
    PubMed    
    Abstract available

  75. WAXMAN AB, Elia D, Adir Y, Humbert M, et al
    Recent advances in the management of pulmonary hypertension with interstitial lung disease.
    Eur Respir Rev. 2022;31.
    PubMed    
    Abstract available

  76. MURUGESAN P, Zhang Y, Youn JY, Cai H, et al
    Novel and robust treatment of pulmonary hypertension with netrin-1 and netrin-1-derived small peptides.
    Redox Biol. 2022;55:102348.
    PubMed    
    Abstract available

  77. ZAPATA-SUDO G
    Riociguat: An Alternative to Treat Pulmonary Hypertension.
    Arq Bras Cardiol. 2022;119:111-112.
    PubMed    


  78. BOXHAMMER E, Paar V, Jirak P, Koller C, et al
    Main pulmonary artery diameter in combination with cardiovascular biomarkers. New possibilities to identify pulmonary hypertension in patients with severe aortic valve stenosis?
    Minerva Med. 2022 Jul 13. pii: S0026-4806.22.08167.
    PubMed    
    Abstract available

  79. RODRIGUEZ-ARIAS JJ, Garcia-Alvarez A
    Sex Differences in Pulmonary Hypertension.
    Front Aging. 2021;2:727558.
    PubMed    
    Abstract available

  80. SILVA VBC, Froes TR, Wolf M, Lucina SB, et al
    Characterization of Doppler spectrum of hepatic veins in dogs with pulmonary hypertension.
    Res Vet Sci. 2022;150:131-136.
    PubMed    
    Abstract available

  81. SHAHIN Y, Alabed S, Alkhanfar D, Tschirren J, et al
    Quantitative CT Evaluation of Small Pulmonary Vessels Has Functional and Prognostic Value in Pulmonary Hypertension.
    Radiology. 2022 Jul 12:210482. doi: 10.1148/radiol.210482.
    PubMed    
    Abstract available

  82. MOORE JE, Cerne JW, Pathrose A, Veer M, et al
    Quantitative Assessment of Regional Pulmonary Transit Times in Pulmonary Hypertension.
    J Magn Reson Imaging. 2022 Jul 9. doi: 10.1002/jmri.28343.
    PubMed    
    Abstract available

  83. ARRIAZA K, Cuevas C, Pena E, Siques P, et al
    Impact of Zinc on Oxidative Signaling Pathways in the Development of Pulmonary Vasoconstriction Induced by Hypobaric Hypoxia.
    Int J Mol Sci. 2022;23.
    PubMed    
    Abstract available

  84. LI Y, Zhang Y, Jiang G, Wang Y, et al
    Case report: novel mutations of NDUFS6 and NHLRC2 genes potentially cause the quick postnatal death of a Chinese Hani minority neonate with mitochondrial complex I deficiency and FINCA syndrome.
    Medicine (Baltimore). 2022;101:e29239.
    PubMed    
    Abstract available

  85. HU P, Xu Y, Jiang Y, Huang J, et al
    The mechanism of the imbalance between proliferation and ferroptosis in pulmonary artery smooth muscle cells based on the activation of SLC7A11.
    Eur J Pharmacol. 2022;928:175093.
    PubMed    
    Abstract available

  86. TANIZAWA K, Handa T, Nagai S, Ikezoe K, et al
    Lung function decline in sarcoidosis.
    Respir Investig. 2022;60:551-561.
    PubMed    
    Abstract available

  87. REZAEI-KALANTARI K, Samimi K, Zomorodian H, Bakhshandeh H, et al
    Pulmonary Blood Volume Measured by Dual-Energy Computed Tomography Can Help Distinguish Patients With Pulmonary Hypertension.
    Front Cardiovasc Med. 2022;9:835655.
    PubMed    
    Abstract available

  88. HANDLER SS, Jin J, Ogawa MT, Feinstein JA, et al
    Abnormal platelet aggregation in pediatric pulmonary hypertension.
    Pulm Circ. 2022;12:e12104.
    PubMed    
    Abstract available

  89. LIU R, Xu C, Zhang W, Cao Y, et al
    FUNDC1-mediated mitophagy and HIF1alpha activation drives pulmonary hypertension during hypoxia.
    Cell Death Dis. 2022;13:634.
    PubMed    
    Abstract available

  90. LI Y, Cai H, Wei J, Zhu L, et al
    Dihydroartemisinin Attenuates Hypoxic Pulmonary Hypertension via the Downregulation of miR-335 Targeting Vangl2.
    DNA Cell Biol. 2022 Jul 19. doi: 10.1089/dna.2021.1113.
    PubMed    
    Abstract available

  91. LUTSEY PL, Evensen LH, Thenappan T, Prins KW, et al
    Incidence and Risk Factors of Pulmonary Hypertension After Venous Thromboembolism: An Analysis of a Large Health Care Database.
    J Am Heart Assoc. 2022;11:e024358.
    PubMed    
    Abstract available

  92. GLUSCHKE H, Siegert E, Minich WB, Hackler J, et al
    Autoimmunity to Sphingosine-1-Phosphate-Receptors in Systemic Sclerosis and Pulmonary Arterial Hypertension.
    Front Immunol. 2022;13:935787.
    PubMed    
    Abstract available

  93. CAI Z, Tian S, Klein T, Tu L, et al
    Kynurenine metabolites predict survival in pulmonary arterial hypertension: A role for IL-6/IL-6Ralpha.
    Sci Rep. 2022;12:12326.
    PubMed    
    Abstract available

  94. DANDEL M, Hetzer R
    Particular Challenges in the Use of Pulmonary Vasodilating Therapy for Patients with Pulmonary Hypertension Secondary to Left Heart Diseases.
    Eur J Heart Fail. 2022 Jul 19. doi: 10.1002/ejhf.2622.
    PubMed    


  95. NAGATA J, Sekine A, Tanabe N, Taniguchi Y, et al
    Mixed venous oxygen tension is a crucial prognostic factor in pulmonary hypertension: a retrospective cohort study.
    BMC Pulm Med. 2022;22:282.
    PubMed    
    Abstract available

  96. ABU T, Levi A, Hasdai D, Kramer MR, et al
    Correction to: Preoperative evaluation of pulmonary hypertension in lung transplant candidates: echocardiography versus right heart catheterization.
    BMC Cardiovasc Disord. 2022;22:324.
    PubMed    


  97. CAO N, Aikeremu N, Shi WY, Tang XC, et al
    Inhibition of KIR2.1 decreases pulmonary artery smooth muscle cell proliferation and migration.
    Int J Mol Med. 2022;50.
    PubMed    
    Abstract available

  98. REMES A, Korbelin J, Arnold C, Rohwedder C, et al
    AAV-mediated gene transfer of inducible nitric oxide synthase (iNOS) to an animal model of pulmonary hypertension.
    Hum Gene Ther. 2022 Jul 19. doi: 10.1089/hum.2021.
    PubMed    
    Abstract available

  99. NEZAMI N, Garg T
    Editorial for "Quantitative Assessment of Regional Pulmonary Transit Times in Pulmonary Hypertension".
    J Magn Reson Imaging. 2022 Jul 18. doi: 10.1002/jmri.28361.
    PubMed    


  100. XU J, Zhong Y, Yin H, Linneman J, et al
    Methylation-mediated silencing of PTPRD induces pulmonary hypertension by promoting pulmonary arterial smooth muscle cell migration via the PDGFRB/PLCgamma1 axis.
    J Hypertens. 2022 Jul 14. pii: 00004872-990000000-00040.
    PubMed    
    Abstract available

  101. CHAN RK, Horrigan M, Goh NSL, Khor YH, et al
    Clinical Assessment for Pulmonary Hypertension in Interstitial Lung Disease.
    Intern Med J. 2022 Jul 18. doi: 10.1111/imj.15887.
    PubMed    
    Abstract available

  102. LI Q, Xin W, Ding H, Zhang Y, et al
    Total flavones from Sceptridium ternatum alleviate pulmonary hypertension through inhibiting the proliferation of vascular endothelial cells.
    Ann Transl Med. 2022;10:677.
    PubMed    
    Abstract available

  103. HASAN H, Chouvarine P, Diekmann F, Diedrich N, et al
    Validation of the New Pediatric Pulmonary Hypertension Risk Score by CMR and Speckle Tracking Echocardiography.
    Eur J Clin Invest. 2022 Jul 17:e13835. doi: 10.1111/eci.13835.
    PubMed    
    Abstract available

  104. JI L, Su S, Xin M, Zhang Z, et al
    Luteolin ameliorates hypoxia-induced pulmonary hypertension via regulating HIF-2alpha-Arg-NO axis and PI3K-AKT-eNOS-NO signaling pathway.
    Phytomedicine. 2022;104:154329.
    PubMed    
    Abstract available

  105. JIANG DT, Tuo L, Bai X, Bing WD, et al
    Prostaglandin E1 reduces apoptosis and improves the homing of mesenchymal stem cells in pulmonary arterial hypertension by regulating hypoxia-inducible factor 1 alpha.
    Stem Cell Res Ther. 2022;13:316.
    PubMed    
    Abstract available

  106. RAMARAJ AB, Rice-Townsend SE, Foster CL, Yung D, et al
    Trends in use of prostacyclin analogs for management of CDH-associated pulmonary hypertension.
    Pediatr Surg Int. 2022 Jul 16. pii: 10.1007/s00383-022-05176.
    PubMed    
    Abstract available

  107. DONG C, Li Y
    Exercise Rehabilitation Training in Patients with Pulmonary Hypertension: A Review.
    Heart Lung Circ. 2022 Jul 12. pii: S1443-9506(22)00937.
    PubMed    
    Abstract available

  108. MA G, Wang D, Xu X, Liang L, et al
    Case report: apatinib plus selexipag as a novel therapy for pulmonary tumor thrombotic microangiopathy accompanied by pulmonary hypertension associated with gastric carcinoma.
    Medicine (Baltimore). 2022;101:e29412.
    PubMed    
    Abstract available

  109. JIANG L, Goncharov DA, Shen Y, Lin D, et al
    Akt-Dependent Glycolysis-Driven Lipogenesis Supports Proliferation and Survival of Human Pulmonary Arterial Smooth Muscle Cells in Pulmonary Hypertension.
    Front Med (Lausanne). 2022;9:886868.
    PubMed    
    Abstract available

  110. NGUYEN MC, Po-Yu Chiang T, Massie AB, Bae S, et al
    Kidney Transplantation Confers Survival Benefit for Candidates With Pulmonary Hypertension.
    Transplant Direct. 2021;7:e738.
    PubMed    
    Abstract available

  111. ZHAI YN, Li AL, Tao XC, Xie WM, et al
    A simpler noninvasive method of predicting markedly elevated pulmonary vascular resistance in patients with chronic thromboembolic pulmonary hypertension.
    Pulm Circ. 2022;12:e12102.
    PubMed    
    Abstract available

  112. CASTILLO JP, Robledo AM, Torres-Canchala L, Roa-Saldarriaga L, et al
    Gigantomastia as a Cause of Pulmonary Hypertension.
    Arch Plast Surg. 2022;49:369-372.
    PubMed    
    Abstract available

  113. NAKANO Y, Adachi S, Nishiyama I, Yasuda K, et al
    Right ventricular pressure overload related to residual thrombotic burden in patients 1 year after acute pulmonary embolism: From the Nagoya PE study.
    Thromb Res. 2022;216:113-119.
    PubMed    
    Abstract available

  114. XU Y, Guo X, Ning S, He Q, et al
    Inhibition of IP3R3 attenuates endothelial to mesenchymal transition induced by TGF-beta1 through restoring mitochondrial function.
    Biochem Biophys Res Commun. 2022;619:144-150.
    PubMed    
    Abstract available

  115. BAUER-RUSEK S, Samra N, Moore SS, Arnon S, et al
    Paracetamol Treatment for Patent Ductus Arteriosus, an Apparent Association with Acute Hemolysis in Three Preterm Infants: Case Series.
    Neonatology. 2022 Jun 21:1-5. doi: 10.1159/000525128.
    PubMed    
    Abstract available

  116. KARVASARSKI E, Zarathus-Cook M, Wright SP
    Catching the wave at the wrong time: Arrival timing provides additional insight into right ventricular afterload in pulmonary arterial hypertension.
    J Physiol. 2022;600:3225-3226.
    PubMed    


  117. KOSTURA M, Smalley C, Koyfman A, Long B, et al
    Right heart failure: A narrative review for emergency clinicians.
    Am J Emerg Med. 2022;58:106-113.
    PubMed    
    Abstract available

  118. ELCIOGLU BC, Baydar O, Helvaci F, Karatas C, et al
    Evaluation of pulmonary arterial stiffness and comparison with right ventricular functions in patients with cirrhosis preparing for liver transplantation.
    J Clin Ultrasound. 2022;50:749-755.
    PubMed    
    Abstract available

  119. SHIMBO M, Hatano M, Ishii S, Saito A, et al
    Renal replacement therapy as a therapeutic option for right heart failure in severe pulmonary arterial hypertension.
    ESC Heart Fail. 2022;9:2728-2731.
    PubMed    
    Abstract available

  120. RAFIKOV R, Rischard F, Vasilyev M, Varghese MV, et al
    Cytokine profiling in pulmonary arterial hypertension: the role of redox homeostasis and sex.
    Transl Res. 2022;247:1-18.
    PubMed    
    Abstract available

  121. OISHI H, Matsuda Y, Ejima Y, Toyama H, et al
    Changes in haemodynamics during single lung transplantation under venovenous extracorporeal membrane oxygenation.
    Interact Cardiovasc Thorac Surg. 2022;35.
    PubMed    
    Abstract available

  122. AWAD A, Elnemr S, Hodeib H, El Amrousy D, et al
    Platelet Activation Markers in Children with Pulmonary Arterial Hypertension Associated with Congenital Heart Disease.
    Pediatr Cardiol. 2022;43:1264-1270.
    PubMed    
    Abstract available

  123. MING Y, Wu Z, Wu Z, Chu S, et al
    Effects of different anesthesia methods on maternal and neonatal outcomes in pregnant patients with pulmonary arterial hypertension: a meta-analysis.
    Arch Gynecol Obstet. 2022;306:7-15.
    PubMed    
    Abstract available

  124. BRIDA M, Chessa M, Celermajer D, Li W, et al
    Atrial septal defect in adulthood: a new paradigm for congenital heart disease.
    Eur Heart J. 2022;43:2660-2671.
    PubMed    
    Abstract available

  125. CAETANO J, Batista F, Amaral MC, Oliveira S, et al
    Acute hospitalization in a cohort of patients with systemic sclerosis: a 10-year retrospective cohort study.
    Rheumatol Int. 2022;42:1393-1402.
    PubMed    
    Abstract available

  126. PRASAD CS, Kumar S, Sumathy S, Kunjukutty R, et al
    Pregnancy and pulmonary arterial hypertension-improving surveillance and outcomes with multidisciplinary care and N terminal pro-brain natriuretic peptide trends.
    J Matern Fetal Neonatal Med. 2022;35:3533-3539.
    PubMed    
    Abstract available

  127. LEE MH, Sanders L, Kumar R, Hernandez-Saavedra D, et al
    Contribution of Fatty Acid Oxidation to the Pathogenesis of Pulmonary Hypertension.
    Am J Physiol Lung Cell Mol Physiol. 2022 Jun 28. doi: 10.1152/ajplung.00039.2022
    PubMed    
    Abstract available

  128. CAMPBELL NV, Mickael C, Kumar S, Zhang H, et al
    Single-cell RNA sequencing and binary hierarchical clustering define lung interstitial macrophage heterogeneity in response to hypoxia.
    Am J Physiol Lung Cell Mol Physiol. 2022;323:L58-L68.
    PubMed    
    Abstract available

  129. HERSI K, Elinoff JM
    Pulmonary Hypertension due to Interstitial Lung Disease: A New iNKlinig into Disease Pathobiology.
    Am J Respir Crit Care Med. 2022 Jun 30. doi: 10.1164/rccm.202206-1186.
    PubMed    


  130. JANDL K, Marsh LM, Mutgan AC, Crnkovic S, et al
    Impairment of the NKT-STAT1-CXCL9-axis Contributes to Vessel Fibrosis in Pulmonary Hypertension Due to Lung Fibrosis.
    Am J Respir Crit Care Med. 2022 Jun 28. doi: 10.1164/rccm.202201-0142.
    PubMed    
    Abstract available

  131. WERTHEIM BM
    New Tricks for an Old Drug: Prostacyclins and Right Ventricular Contractility in Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2022;206:12-13.
    PubMed    


  132. FRECH TM, Austin ED
    Is It Still "Idiopathic"? Features of Autoimmunity in Idiopathic Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2022;206:8-10.
    PubMed    


  133. JONES RJ, De Bie EMDD, Groves E, Zalewska KI, et al
    Autoimmunity Is a Significant Feature of Idiopathic Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2022;206:81-93.
    PubMed    
    Abstract available

  134. CZAPLA J, Claus I, Martens T, Philipsen T, et al
    Midterm comparison between different annuloplasty techniques for functional tricuspid regurgitation.
    Ann Thorac Surg. 2021 Aug 25. pii: S0003-4975(21)01465.
    PubMed    
    Abstract available

  135. BRITTAIN EL, Thenappan T, Huston JH, Agrawal V, et al
    Elucidating the Clinical Implications and Pathophysiology of Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction: A Call to Action: A Science Advisory From the American Heart Association.
    Circulation. 2022 Jul 11:101161CIR0000000000001079.
    PubMed    
    Abstract available

  136. SEMEN KO, Bast A
    Senescence in pulmonary arterial hypertension: is there a link?
    Curr Opin Pulm Med. 2022;28:303-306.
    PubMed    
    Abstract available

  137. GARCIA AR, Piccari L
    Emerging phenotypes of pulmonary hypertension associated with COPD a field guide.
    Curr Opin Pulm Med. 2022 Jul 16. pii: 00063198-990000000-00012.
    PubMed    
    Abstract available

  138. KENNEDY JLW, Mihalek AD
    Update in approaches to pulmonary hypertension because of left heart disease.
    Curr Opin Pulm Med. 2022 Jul 16. pii: 00063198-990000000-00013.
    PubMed    
    Abstract available

  139. GOLOVENKO O, Lazorhyshynets V, Prokopovych L, Truba Y, et al
    Early and Long-term Results of Ventricular Septal Defect Repair in Children with Severe Pulmonary Hypertension and Elevated Pulmonary Vascular Resistance by Double or Traditional Patch Technique.
    Eur J Cardiothorac Surg. 2022 Jun 29. pii: 6619555. doi: 10.1093.
    PubMed    
    Abstract available

  140. NISHIKAWA H, Yamashita K, Niwa K, Taniguchi S, et al
    Coronary-pulmonary arterial fistula with anomalous origin and aneurysms of the coronary arteries.
    Eur J Cardiothorac Surg. 2022;62.
    PubMed    


  141. SU AY, Vinogradsky A, Wang AS, Ning Y, et al
    Impact of sex, race and socioeconomic status on survival after pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension.
    Eur J Cardiothorac Surg. 2022;62.
    PubMed    
    Abstract available

  142. WESSELS JN, Mouratoglou SA, van Wezenbeek J, Handoko ML, et al
    Right atrial function is associated with right venticular diastolic stiffness: RA-RV interaction in pulmonary arterial hypertension.
    Eur Respir J. 2022;59.
    PubMed    
    Abstract available

  143. LIU B, Peng Y, Yi D, Machireddy N, et al
    Endothelial PHD2 deficiency induces nitrative stress via suppression of caveolin-1 in pulmonary hypertension.
    Eur Respir J. 2022 Jul 7. pii: 13993003.02643-2021.
    PubMed    
    Abstract available

  144. STUBBS H, Lua S, Brewis M, Johnson M, et al
    COMPERA 2.0 risk stratification in medically-managed chronic thromboembolic pulmonary hypertension.
    Eur Respir J. 2022 Jul 7. pii: 13993003.00313-2022.
    PubMed    


  145. JUTANT EM, Tu L, Thuillet R, Picard V, et al
    Erythrocytes are altered in pulmonary arterial hypertension.
    Eur Respir J. 2022;59.
    PubMed    


  146. GHOFRANI HA
    Selexipag for inoperable CTEPH: why meeting a primary endpoint simply isn't enough.
    Eur Respir J. 2022;60.
    PubMed    


  147. DU M, Jiang H, Liu H, Zhao X, et al
    Single-cell RNA sequencing reveals that BMPR2 mutation regulates right ventricular function via ID genes.
    Eur Respir J. 2022;60.
    PubMed    
    Abstract available

  148. HOEPER MM, Pausch C, Olsson KM, Huscher D, et al
    COMPERA 2.0: a refined four-stratum risk assessment model for pulmonary arterial hypertension.
    Eur Respir J. 2022;60.
    PubMed    
    Abstract available

  149. REDDY SA, Nethercott SL, Teh W, De Bie EM, et al
    Prevalence and clinical significance of conduction disease in patients with idiopathic pulmonary arterial hypertension.
    J Heart Lung Transplant. 2022;41:861-865.
    PubMed    
    Abstract available

  150. HOEPER MM, Pausch C, Olsson KM, Huscher D, et al
    Prognostic value of improvement endpoints in pulmonary arterial hypertension trials: A COMPERA analysis.
    J Heart Lung Transplant. 2022;41:971-981.
    PubMed    
    Abstract available

  151. GOLDSTONE AB, Bacha EA, Rosenzweig EB
    Commentary: Keeping the reversed Potts shunt reversed: Insights from the fourth dimension.
    J Thorac Cardiovasc Surg. 2022;164:342-343.
    PubMed    


  152. SCHAFER M, Frank BS, Grady RM, Eghtesady P, et al
    Monitoring and evaluation of the surgical Potts shunt physiology using 4-dimensional flow magnetic resonance imaging.
    J Thorac Cardiovasc Surg. 2022;164:331-341.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;